The next “sweet” spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detection
Authors:
- 12 November 2021
- journal article
- review article
- Published by Wiley in Mass Spectrometry Reviews
- Vol. 42 (2) , 822-843
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is the most common neoplastic disease of the pancreas, accounting for more than 90% of all pancreatic malignancies. As a highly lethal malignancy, PDAC is the fourth leading cause of cancer‐related deaths worldwide with a 5‐year overall survival of less than 8%. The efficacy and outcome of PDAC treatment largely depend on the stage of disease at the time of diagnosis. Surgical resection followed by adjuvant chemotherapy remains the only possibly curative therapy, yet 80%–90% of PDAC patients present with nonresectable PDAC stages at the time of clinical presentation. Despite our advancing knowledge of PDAC, the prognosis remains strikingly poor, which is primarily due to the difficulty of diagnosing PDAC at the early stages. Recent advances in glycoproteomics and glycomics based on mass spectrometry have shown that aberrations in protein glycosylation plays a critical role in carcinogenesis, tumor progression, metastasis, chemoresistance, and immuno‐response of PDAC and other types of cancers. A growing interest has thus been placed upon protein glycosylation as a potential early detection biomarker for PDAC. We herein take stock of the advancements in the early detection of PDAC that were carried out with mass spectrometry, with special focus on protein glycosylation.Keywords
This publication has 235 references indexed in Scilit:
- iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performanceBritish Journal of Cancer, 2013
- GlycoPep Grader: A Web-Based Utility for Assigning the Composition ofN-Linked GlycopeptidesAnalytical Chemistry, 2012
- Identification of Glycoprotein Markers for Pancreatic Cancer CD24+CD44+ Stem-like Cells Using Nano-LC–MS/MS and Tissue MicroarrayJournal of Proteome Research, 2012
- Relative Quantification of Serum Proteins from Pancreatic Ductal Adenocarcinoma Patients by Stable Isotope Dilution Liquid Chromatography–Mass SpectrometryJournal of Proteome Research, 2012
- Identification of blood‐protein carriers of the CA 19‐9 antigen and characterization of prevalence in pancreatic diseasesProteomics, 2011
- Protein Alterations Associated with Pancreatic Cancer and Chronic Pancreatitis Found in Human Plasma using Global Quantitative Proteomics ProfilingJournal of Proteome Research, 2011
- Glycomics Hits the Big TimeCell, 2010
- Quantitative proteomics investigation of pancreatic intraepithelial neoplasiaElectrophoresis, 2009
- Chemical Approaches To Perturb, Profile, and Perceive GlycansAccounts of Chemical Research, 2009
- New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancerThe Lancet Oncology, 2009